We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$80.5B
AUM Growth
-$3.46B
(-4.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
13.64%
Holding
817
New
51
Increased
266
Reduced
358
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$499M |
| 2 |
Fidelity National Information Services
FIS
|
+$462M |
| 3 |
Honeywell
HON
|
+$367M |
| 4 |
Lennar Class A
LEN
|
+$321M |
| 5 |
Extra Space Storage
EXR
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$486M |
| 2 |
Global Payments
GPN
|
+$421M |
| 3 |
Eaton
ETN
|
+$415M |
| 4 |
Dell
DELL
|
+$391M |
| 5 |
Howmet Aerospace
HWM
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.82% |
| 2 | Technology | 16.67% |
| 3 | Industrials | 16.22% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Deere & Co
DE
$167B
| $151M | 0.19% |
406,414
-581
| -0.1% | -$227K |
|
177
Merck
MRK
$365B
| $151M | 0.19% |
1,221,091
-39,489
| -3% | -$5.09M |
|
178
Ares Management
ARES
$32.5B
| $151M | 0.19% |
1,131,849
-827,991
| -42% | -$113M |
|
179
The Mosaic Company
MOS
$7.52B
| $149M | 0.19% |
5,165,362
+3,886,340
| +304% | +$117M |
|
180
CDW
CDW
$18.8B
| $146M | 0.18% |
650,561
-157,029
| -19% | -$36.4M |
|
181
Atkore
ATKR
$3.16B
| $146M | 0.18% |
1,075,937
-264,209
| -20% | -$42.1M |
|
|
182
Sanofi
SNY
$107B
| $145M | 0.18% |
2,984,025
-10,082,378
| -77% | -$486M |
|
183
East-West Bancorp
EWBC
$17.8B
| $142M | 0.18% |
1,939,535
-7,097
| -0.4% | -$526K |
|
184
Bristol-Myers Squibb
BMY
$136B
| $140M | 0.17% |
3,378,829
-7,016,591
| -67% | -$314M |
|
185
Visa
V
$715B
| $139M | 0.17% |
530,285
-17,222
| -3% | -$4.72M |
|
186
OGE Energy
OGE
$9.49B
| $138M | 0.17% |
3,864,387
+48,539
| +1% | +$1.7M |
|
187
DuPont de Nemours
DD
$18.5B
| $131M | 0.16% |
1,296,058
-2,043,059
| -61% | -$200M |
|
188
Resideo Technologies
REZI
$3.03B
| $130M | 0.16% |
6,629,255
-71,309
| -1% | -$1.48M |
|
189
Rexford Industrial Realty
REXR
$8.26B
| $128M | 0.16% |
2,876,809
-13,876
| -0.5% | -$625K |
|
190
Rocket Companies
RKT
$40.4B
| $128M | 0.16% |
9,313,281
-68,892
| -0.7% | -$931K |
|
191
Boyd Gaming
BYD
$5.8B
| $127M | 0.16% |
2,306,001
-725,090
| -24% | -$41.4M |
|
192
Generac Holdings
GNRC
$11.3B
| $123M | 0.15% |
+930,324
| New | +$129M |
|
193
Tidewater
TDW
$4.64B
| $123M | 0.15% |
1,285,943
-1,037,782
| -45% | -$102M |
|
194
Analog Devices
ADI
$177B
| $119M | 0.15% |
522,279
-16,732
| -3% | -$3.57M |
|
195
Allison Transmission
ALSN
$10.4B
| $118M | 0.15% |
1,551,167
-54,376
| -3% | -$4.17M |
|
196
Lear
LEA
$8.26B
| $116M | 0.14% |
1,015,579
-7,586
| -0.7% | -$971K |
|
197
Acuity Brands
AYI
$10B
| $115M | 0.14% |
476,006
-209,052
| -31% | -$53.4M |
|
198
NOV
NOV
$7.36B
| $115M | 0.14% |
6,048,722
-91,888
| -1% | -$1.72M |
|
199
Invitation Homes
INVH
$17.5B
| $115M | 0.14% |
3,194,652
-24,253
| -0.8% | -$843K |
|
200
Affiliated Managers Group
AMG
$9.7B
| $113M | 0.14% |
+720,788
| New | +$115M |
|
Similar funds
Boston Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Boston Partners held 817 positions worth $80.5B, down 4.1% from $84B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q2 2024 filing shows 51 new, 266 increased, 358 reduced and 117 closed positions. Its largest new stake was Honeywell: 1,930,615 shares worth $389M. The largest sale was Sanofi, an estimated $486M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q2 2024 buy was Honeywell: 1,930,615 shares worth $389M.
- Boston Partners added most to AbbVie in Q2 2024, an estimated $499M increase.
- Boston Partners's biggest Q2 2024 reduction was Sanofi, cutting an estimated $486M.
- Boston Partners fully exited Globe Life in Q2 2024, selling an estimated $243M.
- Boston Partners's ten largest holdings make up 14% of its $80.5B portfolio in Q2 2024.
- Boston Partners opened 51 new positions and closed 117 in Q2 2024.
- Boston Partners's portfolio value fell 4.1% quarter-over-quarter to $80.5B.
Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.